BTAI Investors Have Opportunity to Lead BioXcel Therapeutics, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., July 18, 2023 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI). Class Period:…